SVB Leerink Maintains Market Perform on Twist Bioscience, Lowers Price Target to $30
SVB Leerink analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Market Perform and lowers the price target from $45 to $30.
Earnings Scheduled For November 18, 2022
Companies Reporting Before The Bell
• So-Young Intl (NASDAQ:SY) is estimated to report quarterly earnings at $0.14 per share on revenue of $62.46 million.
Why Fast Radius Shares Plunged Around 48%; Here Are 103 Biggest Movers From Yesterday
Gainers
Satixfy Communications Ltd. (NYSE: SATX) shares gained 140.7% to settle at $31.80 on Tuesday.
Why Opiant Pharmaceuticals Shares Are Trading Higher By 115%? Here Are 67 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
SenesTech, Inc. (NASDAQ: SNES) shares surged 91.7% to $0.2751. SenesTech reported a 1-for-20 reverse stock split.
Vodafone, Getty Images Holdings, Haynes International And Some Other Big Stocks Moving Lower On Tuesday
U.S. stocks traded higher, with the Nasdaq gaining more than 200 points on Tuesday. Here are some big stocks recording losses in today’s session.
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday’s Mid-Day Session
Gainers
Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
SVB Leerink Maintains Market Perform on Twist Bioscience, Lowers Price Target to $45
SVB Leerink analyst Puneet Souda maintains Twist Bioscience (NASDAQ:TWST) with a Market Perform and lowers the price target from $50 to $45.
Where Twist Bioscience Stands With Analysts
Over the past 3 months, 4 analysts have published their opinion on Twist Bioscience (NASDAQ:TWST) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.
FDA To Review Smaller Number Of Emergency Use Requests For COVID-19 Tests
The FDA said it will now review only a small number of emergency use authorization (EUA) requests for COVID-19 diagnostic…